Could be but eventually they know they have to be SEC compliant. I don't think waiting enough time would remove them from liability. I know this is all speculation but I really don't know. It's a good question
Wow, that is a ridiculous statement! RXMD is audited for several years now and recently changed to an SEC reporting auditor that reviewed prior filings. RXMD currently files through the OTC alternative process, still an official formal filing, and subject to the same scrutiny of truthfulness as an SEC filing.
No dangling carrots here. Just aggressive conversion of outstanding note. Their financials have been audited for several years by third party prior to reporting. They would have to be very foolish to "fudge the books" with an uplist in the near future and S1 in progress. Good attempt at trying to get cheaper shares though.
Market Data 
Markets 
AI
